Skip to Content

UK Edition. Click here for US version.

OLANZAPINE CADUCEUS 5 MG FILM-COATED TABLETS

Active substance(s): OLANZAPINE

View full screen / Print PDF » Download PDF ⇩
Transcript
Package leaflet: Information for the user
Olanzapine 2.5 mg film-coated tablets
Olanzapine 5 mg film-coated tablets
Olanzapine 7.5 mg film-coated tablets
Olanzapine 10 mg film-coated tablets
Olanzapine 15 mg film-coated tablets
Olanzapine 20 mg film-coated tablets
Olanzapine
Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
-

Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist or nurse..
This medicine has been prescribed for you only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same as yours.
If you get any side effects talk to your doctor, pharmacist or nurse.This includes any
possible side effects not listed in this leaflet.

What is in this leaflet:
1.
What Olanzapine is and what it is used for
2.
What you need to know before you take Olanzapine
3.
How to take Olanzapine
4.
Possible side effects
5.
How to store Olanzapine
6.
Contents of the pack and other information

1.

What Olanzapine is and what it is used for

Olanzapine belongs to a group of medicines called antipsychotics and is used to treat the
following conditions:
- Schizophrenia, a disease with symptoms such as hearing, seeing or sensing things which
are not there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn. People
with this disease may also feel depressed, anxious or tense.
- Moderate to severe manic episodes, a condition with symptoms of excitement or euphoria.
Olanzapine has been shown to prevent recurrence of these symptoms in patients with bipolar
disorder whose manic episode has responded to olanzapine treatment.

2.

What you need to know before you take Olanzapine

Do not take Olanzapine
if you are allergic to olanzapine or any of the other ingredients of this medicine (listed in
section 6). An allergic reaction may be recognised as a rash, itching, a swollen face,
swollen lips or shortness of breath. If this has happened to you, tell your doctor.

-

if you have been previously diagnosed with eye problems such as certain kinds of
glaucoma (increased pressure in the eye).

Warnings and precautions
Talk to your doctor or pharmacist before taking Olanzapine.
The use of Olanzapine Tablets in elderly patients with dementia is not recommended as it
may have serious side effects.
Medicines of this type may cause unusual movements mainly of the face or tongue. If this
happens after you have been given Olanzapine tell your doctor.
Very rarely, medicines of this type cause a combination of fever, faster breathing,
sweating, muscle stiffness and drowsiness or sleepiness. If this happens, contact your
doctor at once.
Weight gain has been seen in patients taking Olanzapine Tablets. You and your doctor
should check your weight regularly.
High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in
patients taking Olanzapine Tablets. Your doctor should do blood tests to check blood sugar
and certain fat levels before you start taking Olanzapine Tablets and regularly during
treatment.
Tell the doctor if you or someone else in your family has a history of blood clots, as
medicines like these have been associated with the formation of blood clots.
If you suffer from any of the following illnesses tell your doctor as soon as possible:
-

Stroke or “mini” stroke (temporary symptoms of stroke)
Parkinson’s disease
Prostate problems
A blocked intestine (Paralytic ileus)
Liver or kidney disease
Blood disorders
Heart disease
Diabetes
Seizures

If you suffer from dementia, you or your carer/relative should tell your doctor if you have ever
had a stroke or “mini” stroke.
As a routine precaution, if you are over 65 years your blood pressure may be monitored by your
doctor.
Children and adolescents
Olanzapine is not for patients who are under 18 years.
Other medicinesand Olanzapine
Only take other medicines while you are on Olanzapine if your doctor tells you that you can. You
might feel drowsy if Olanzapine is taken in combination with antidepressants or medicines taken
for anxiety or to help you sleep (tranquillisers).
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines.

In particular, tell your doctor if you are taking:
- medicines for Parkinson’s disease.
- carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepressant) or
ciprofloxacin (an antibiotic) - it may be necessary to change your Olanzapine dose.
Olanzapine with food, drink and alcohol
Do not drink any alcohol if you have been given Olanzapine as together with alcohol it may make
you feel drowsy.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby,
ask your doctor for advice before taking this medicine. You should not be given this medicine
when breast-feeding, as small amounts of Olanzapine can pass into breast milk.
The following symptoms may occur in newborn babies, of mothers that have used Olanzapine in
the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or
weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby
develops any of these symptoms you may need to contact your doctor.
Driving and using machines
There is a risk of feeling drowsy when you are given Olanzapine. If this happens do not drive or
operate any tools or machines. Tell your doctor.
Olanzapine tablets contain lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your
doctor before taking this medicinal product.
Olanzapine tablets contain lecithin soya
If you are allergic to peanut or soya, do not take this medicine.

3.

How to take Olanzapine

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your
doctor or pharmacist if you are not sure.
Your doctor will tell you how many Olanzapine tablets to take and how long you should continue
to take them. The daily dose of Olanzapine is between 5 and 20 mg. Consult your doctor if your
symptoms return but do not stop taking Olanzapine unless your doctor tells you to.
You should take your Olanzapine tablets once a day following the advice of your doctor. Try to
take your tablets at the same time each day. It does not matter whether you take them with or
without food.
Olanzapine film-coated tablets are for oral use. You should swallow the Olanzapine tablets whole
with water.
If you take more Olanzapine than you should
Patients who have taken more Olanzapine than they should, have experienced the following
symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual
movements (especially of the face or tongue) and reduced level of consciousness. Other
symptoms may be: acute confusion, seizures (epilepsy), coma, a combination of fever, faster

breathing, sweating, muscle stiffness and drowsiness or sleepiness, slowing of the breathing rate,
aspiration, high blood pressure or low blood pressure, abnormal rhythms of the heart. Contact
your doctor or hospital straight away if you experience any of the above symptoms. Show the
doctor your pack of tablets.
If you forget to take Olanzapine
Take your tablets as soon as you remember. Do not take two doses in one day.
If you stop taking Olanzapine
Do not stop taking your tablets just because you feel better. It is important that you carry on
taking Olanzapine for as long as your doctor tells you.
If you suddenly stop taking Olanzapine, symptoms such as sweating, unable to sleep, tremor,
anxiety or nausea and vomiting might occur. Your doctor may suggest you to reduce the dose
gradually before stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately if you have:
- unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of
the face or tongue;
- blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people)
especially in the legs (symptoms include swelling, pain, and redness in the leg), which may
travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If
you notice any of these symptoms seek medical advice immediately;
- a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or
sleepiness (the frequency of this side effect cannot be estimated from the available data).

Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness;
and increases in levels of prolactin in the blood. In the early stages of treatment, some people may
feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting
position. This will usually pass on its own but if it does not, tell your doctor.
Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood
cells , circulating fats and early in treatment, temporary increases in liver enzymes; increases in the
level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in
the blood; feeling more hungry; dizziness; restlessness; tremor;; unusual movements(dyskinesias);
constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling
of the hands, ankles or feet; and sexual dysfunctions such as decreased libido in males and females or erectile
dysfunction in males.

Uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in
the mouth and throat, itching, rash); diabetes or the worsening of diabetes, occasionally associated
with ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a

history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); problems
with speech; slow heart rate; sensitivity to sunlight; bleeding from the nose; abdominal distension;
memory loss or forgetfulness; urinary incontinence; lack of ability to urinate; hair loss; absence or
decrease in menstrual periods; and changes in breasts in males and females such as an abnormal
production of breast milk or abnormal growth.
Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature
abnormal rhythms of the heart; sudden unexplained death; inflammation of the pancreas causing
severe stomach pain, fever and sickness; liver disease appearing as yellowing of the skin and white
parts of the eyes; muscle disease presenting as unexplained aches and pains; and prolonged and/or
painful erection.
While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia,
urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature,
redness of the skin and have trouble walking. Some fatal cases have been reported in this
particular group of patients.
In patients with Parkinson’s disease Olanzapine may worsen the symptoms.

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. You can also report side effects directly via Yellow Card
Scheme Website: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.

5.

How to store Olanzapine

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date, which is stated on the carton.
Blister packs:
Store in the original package in order to protect from light and moisture.
Please return left over medicine to your pharmacist.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how
to throw away medicines you no longer use. These measures will help to protect the environment.

6.

Contents of the pack and other information

What Olanzapine contains
The active substance is olanzapine. Each Olanzapine tablet contains either 2.5 mg, 5 mg,
7.5mg, 10 mg, 15 mg or 20 mg of the active substance.
The other ingredients are (tablet core) lactose anhydrous, microcrystalline cellulose,
crospovidone, magnesium stearate and (tablet film-coating) polyvinyl alcohol, titanium

dioxide (E171), talc, lecithin soya (E322) and xanthan gum (E415). In addition the 15 mg
tablets contain indigo carmine (E132) and the 20 mg tablets contain iron oxide red (E172).
What Olanzapine looks like and contents of the pack
Film-coated tablet 2.5 mg: Round, biconvex, white film-coated tablet 6 mm in diameter, marked
with “O” on one side.
Film-coated tablet 5 mg: Round, biconvex, white film-coated tablet 8 mm in diameter, marked
with “O1” on one side.
Film-coated tablet 7.5 mg: Round, biconvex, white film-coated tablet 9 mm in diameter, marked
with “O2” on one side.
Film-coated tablet 10 mg: Round, biconvex, white film-coated tablet 10 mm in diameter, marked
with “O3” on one side.
Film-coated tablet 15 mg: Oval, biconvex, light blue film-coated tablet 7.35 x 13.35 mm in
diameter, marked with “O” on one side.
Film-coated tablet 20 mg: Oval, biconvex, light pink film-coated tablet 7.5 x 14.5 mm in
diameter, marked with “O” on one side.
Pack sizes
In blisters: 7, 14, 28, 30, 35, 56 and 70 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Caduceus Pharma Limited
6th Floor
94 Wigmore Street
London
W1U 3RF
UK
Manufacturer*
Actavis hf
Reykjavikurvegur 76-78
220 Hafnarfjörður
Iceland
Or
Actavis Ltd
BLB 016, Bulebel Industrial Estate
Zejtun ZTN 3000
Malta
*the actual leaflet will only refer to the batch release site that is utilised

This leaflet was last revised in July 2013.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide